|
2025
|
Invention
|
Pharmaceutical composition comprising dual gip and glp-1 receptor agonist. The invention pertains... |
|
|
Invention
|
Stable isoxazoline formulation for topical application to the skin. The invention relates to a ve... |
|
2024
|
Invention
|
Bilayer tablet formulation comprising dapagliflozin and metformin. The present invention relates ... |
|
|
Invention
|
Fixed combination of telmisartan, amlodipine and indapamide for the treatment of hypertension. Th... |
|
|
Invention
|
Immediate release monolayer tablet comprising telmisartan and one or more other antihypertensive ... |
|
|
Invention
|
Pharmaceutical composition comprising benzydamine hydrochloride and cetylpyridinium chloride. The... |
|
|
Invention
|
Tablet comprising enzalutamide. The present invention relates to a tablet composition comprising ... |
|
|
Invention
|
Solid oral composition comprising vericiguat. The invention relates to a solid dispersion compris... |
|
|
Invention
|
Process for the preparation of substituted chalcones. The invention relates to an improved proces... |
|
2023
|
Invention
|
Veterinary composition comprising oclacitinib. The invention relates to veterinary compositions c... |
|
|
Invention
|
Process for the preparation of sitagliptin. The present invention relates to a process for the pr... |
|
|
Invention
|
Ribociclib salts and formulations thereof. 29 KRK0017-WO Abstract: The invention relates to physi... |
|
|
Invention
|
Bilayer tablets of valsartan and indapamide. The invention relates to an oral pharmaceutical dosa... |
|
|
Invention
|
Crystalline form of ibrutinib. The present invention relates to crystalline form of ibrutinib, de... |
|
|
Invention
|
Method for crystallizing tapentadol intermediate, tapentadol intermediate of high purity, method ... |
|
|
Invention
|
Soft chewable veterinary dosage form. The invention relates to a soft chewable veterinary dosage ... |
|
|
Invention
|
Process for purification of linagliptin. The present invention relates to a process for purificat... |
|
2022
|
Invention
|
Pharmaceutical composition comprising apremilast. The present invention relates to a pharmaceutic... |
|
|
Invention
|
Synthesis of (1r,2s,5s)-n-((s)-1-cyano-2-((s)-2-oxopyrrolidin-3-yl)ethyl)-3-((s)-3,3-dimethyl-2- ... |
|
|
Invention
|
Process for preparing sartans. The present application relates to a process for purifying a tetra... |
|
|
Invention
|
Combination of cetylpyridinium and benzydamine with virucidal effect on sars-cov-2. The invention... |
|
|
Invention
|
Process for preparing a pharmaceutical composition comprising linagliptin and metformin hydrochlo... |
|
|
Invention
|
Bilayer tablet comprising telmisartan and indapamide. The invention relates to a bilayer tablet c... |
|
|
Invention
|
Pharmaceutical composition comprising naproxen and paracetamol. The invention relates to a multil... |
|
|
Invention
|
Pharmaceutical formulation of valsartan and sacubitril. The invention relates to a pharmaceutical... |
|
|
Invention
|
Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof. The inve... |
|
2021
|
Invention
|
Edoxaban formulation containing no sugar alcohols. The invention relates to a tablet comprising E... |
|
|
Invention
|
Bilayer tablet comprising ezetimibe and atorvastatin. The invention relates to solid pharmaceutic... |
|
|
Invention
|
Formulation containing dexketoprofen and tramadol and method for making the same. The present inv... |
|
|
Invention
|
Pharmaceutical formulation of metformin having low content of dimethylamine. A metformin starting... |
|
|
Invention
|
Preparation of highly pure amorphous dapagliflozin. A novel and improved process for the preparat... |
|
|
Invention
|
Pharmaceutical composition comprising sglt2 inhibitor. Pharmaceutical compositions are provided w... |
|
2020
|
Invention
|
Composition for the preparation of perindopril arginine granules, a method for their preparation ... |
|
|
Invention
|
Dosage form comprising amorphous solid solution of empagliflozin with polymer. The invention prov... |
|
|
Invention
|
Pharmaceutical composition comprising glp-1 analogue. The present invention discloses new pharmac... |
|
|
Invention
|
Analytical method for iceland moss. An analytical method is disclosed for quantitative determinat... |
|
|
Invention
|
Composition comprising diosmin. The present invention provides a chewable tablet comprising diosm... |
|
|
Invention
|
Process for preparing fluralaner. The invention relates to an improved process for the synthesis ... |
|
2019
|
Invention
|
Pharmaceutical composition comprising apixaban. The present invention relates to pharmaceutical c... |
|
|
Invention
|
Process for preparing apixaban. The present invention relates to process for preparing apixaban, ... |
|
|
Invention
|
A process for the preparation of polymorphic form of robenacoxib. The present invention relates t... |
|
|
Invention
|
Pharmaceutical composition of ticagrelor. The present invention provides solid pharmaceutical for... |
|
2018
|
Invention
|
Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt. The pr... |
|
|
Invention
|
Process for the preparation of agomelatine in crystalline form. The present invention pertains to... |
|
|
Invention
|
Pharmaceutical composition containing agomelatine and process for the preparation thereof. The pr... |
|
|
Invention
|
Stable topical veterinary composition. The present invention is related to a stable topical veter... |
|
2017
|
Invention
|
Crystalline forms of bilastine. The present invention relates to novel solid state forms of bilas... |
|
|
Invention
|
Fast dispersible pharmaceutical composition comprising tyrosine-kinase inhibitor. The present inv... |
|
2015
|
Invention
|
Pharmaceutical tablet composition. The object of the present invention is a pharmaceutical tablet... |
